Target Healthcare REIT (LON:THRL) Sets New 1-Year High – Should You Buy?

Target Healthcare REIT (LON:THRLGet Free Report)’s stock price hit a new 52-week high on Tuesday . The stock traded as high as GBX 93.20 ($1.21) and last traded at GBX 92.80 ($1.20), with a volume of 4599062 shares traded. The stock had previously closed at GBX 86.80 ($1.13).

Target Healthcare REIT Price Performance

The company has a market cap of £555.79 million, a price-to-earnings ratio of 7.61, a price-to-earnings-growth ratio of 1.48 and a beta of 0.44. The company has a fifty day moving average price of GBX 84.22 and a two-hundred day moving average price of GBX 85.80. The company has a current ratio of 7.20, a quick ratio of 1.52 and a debt-to-equity ratio of 34.92.

About Target Healthcare REIT

(Get Free Report)

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.

See Also

Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.